Dr. Amaya is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
13001 E 17th Pl
Aurora, CO 80045Phone+1 303-724-1784
Education & Training
- University of Colorado School of Medicine Anschutz Medical CampusClass of 2017
Certifications & Licensure
- CO State Medical License 2020 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 2 citationsLysosomal acid lipase A modulates leukemia stem cell response to venetoclax/tyrosine kinase inhibitor combination therapy in blast phase chronic myeloid leukemia.Mohd Minhajuddin, Amanda Winters, Haobin Ye, Shanshan Pei, Brett Stevens
Haematologica. 2025-01-01 - Response to intensive induction chemotherapy after failure of frontline azacitidine and venetoclax in acute myeloid leukemia.Kellen B Gil, Diana Abbott, Maria L Amaya, Marc Schwartz, Jonathan A Gutman
Leukemia & Lymphoma. 2024-12-01 - 1 citationsMultiomic profiling identifies predictors of survival in African American patients with acute myeloid leukemia.Andrew Stiff, Maarten Fornerod, Bailee N Kain, Deedra Nicolet, Benjamin J Kelly
Nature Genetics. 2024-11-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: